About Us

PEV Healthcare Consulting works to Enhancing Healthcare Efficiency
Globally Through Data-Driven and Scientifically Substantiated
Consultancy.
Ana Paula Beck da Silva Etges por Fabiano Scheck copy () ()

Ana Paula Beck da Silva Etges, Ph.D

Ana is passionate for inspiring people for scientific education and works for a more effective and sustainable health care system. In addition to her position as Partner from PEV Healthcare Consulting , she serves as Health Economist scientist at Dream Big Health (USA), Professor in the Graduate Program in Epidemiology at UFRGS and at Insper Healthcare Management MBA Program in Brazil, and Senior Researcher at the National Institute for Health Technology Assessment (IATS).

In all her affiliations, she dedicates her career to turning health care costs more transparent and implementing value-based healthcare principles in health care organizations and systems, having most of her consulting and research projects developed for Biotech and Biopharma companies.

Ana has performed dozens of TDABC and health care management research and consulting projects in Brazil, Portugal, and USA. She is continually researching and working to engage more people on the cause to improve the efficiency of health care systems worldwide.

Ana has a Ph.D. in industrial engineering at UFRGS, in collaboration with Stanford Medicine, and completed her post-doctoral fellowship in epidemiology at UFRGS in collaboration with the Brigham Women’s Hospital. She also attended the VBHC Seminary at Harvard Business School and is certificated in Effective Writing for Health Care by the Harvard Medical School (Class 2023).

Ana has an impressive portfolio as an academic and researcher, having been classified as the 5 finalists of the Havard Brazil Conference in 2023 as a valuable researcher for Brazil. She has penned more than 140 publications, all of which focus on the intricate fields of Health Economics, Value-based Care, and Value Creation. Her H-index is 24, and she accounts for around 1000 citations.

Carisi Polanczyk ()

Carisi Anne Polanczyk, ScD

In addition to her position as Partner from PEV Healthcare Consulting, Carisi is an Associate Professor of Medicine at Federal University of Rio Grande do Sul (UFRGS), senior researcher from the Brazilian National Agency (CNPq), attending physician and preceptor at the Cardiology Division at Hospital de Clínicas de Porto Alegre, and chief of the Cardiology Division at Hospital Moinhos de Vento, since 2013.

Prof. Polanczyk is the coordinator of the Institute for Health Technology Assessment (IATS/CNPq) and have dedicated the last decades on studies on health economics, technology assessment and strategies to increase efficiency and value for the health care system, with emphasis on cost-effectiveness, management, and incorporation of new technology. Lately, she has been working on value-based health care (VBHC) implementation and research initiatives, focusing on applying ICHOM standard sets and time-driven activity-based costing methodology. Her additional studies focus on coronary artery disease and perioperative care, with national and international collaboration.

To date, Prof. Polanczyk has published around 300 scientific articles, accounting for more than 21000 citations and ‘h’ index of 221.

Aiming to transform the healthcare system through science, we created PEV

PEV Consulting

Projects on health economics, value-based strategy, technology assessment, and service design.

Consulting projects:

We use specialized approaches for each individual initiative through communication with key stakeholders to support the implementation of projects rooted in science and technology.

Scientific Writing and Communication:

We identify all conceivable data sources, ranging from ancillary data to real-world datasets, to deliver improved solutions for healthcare system challenges.

Speaking:

We apply advanced statistical data analytics to guide effective decision-making.

Partners

Educational institutions and research institutions
with which we maintain collaborations:

International partner companies: